Home
>
National Drug Code (NDC)
>
Labetalol Hydrochloride
Labetalol Hydrochloride - 0409-2339-34 - (Labetalol Hydrochloride)
Drug Information of Labetalol Hydrochloride
| Product NDC: | 0409-2339 |
| Proprietary Name: | Labetalol Hydrochloride |
| Non Proprietary Name: | Labetalol Hydrochloride |
| Active Ingredient(s): | 5 mg/mL & nbsp; Labetalol Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Labetalol Hydrochloride
| Product NDC: | 0409-2339 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075239 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110204 |
Package Information of Labetalol Hydrochloride
| Package NDC: | 0409-2339-34 |
| Package Description: | 10 CARTON in 1 CONTAINER (0409-2339-34) > 1 SYRINGE in 1 CARTON > 4 mL in 1 SYRINGE |
NDC Information of Labetalol Hydrochloride
| NDC Code | 0409-2339-34 |
| Proprietary Name | Labetalol Hydrochloride |
| Package Description | 10 CARTON in 1 CONTAINER (0409-2339-34) > 1 SYRINGE in 1 CARTON > 4 mL in 1 SYRINGE |
| Product NDC | 0409-2339 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Labetalol Hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110204 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | LABETALOL HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
